INTEGRATED BIOPHARMA INC Operating Lease, Liability, Current
INTEGRATED BIOPHARMA INC (INBP) had Operating Lease, Liability, Current of $1.14 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-05-08
- 2026-03-31: Operating Lease, Liability, Current $1.14M.
- 2025-12-31: Operating Lease, Liability, Current $221.00K.
- 2025-09-30: Operating Lease, Liability, Current $429.00K.
- 2025-06-30: Operating Lease, Liability, Current $634.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-03-31 | $1.14M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $221.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $429.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $634.00K 10-Q · filed 2026-05-08 |
| 2025-03-31 | $837.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $964.00K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $954.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $945.00K 10-K · filed 2025-09-23 |
| 2024-03-31 | $935.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $924.00K 10-Q · filed 2024-02-12 |
| 2023-09-30 | $914.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $888.00K 10-K · filed 2024-09-20 |
| 2023-03-31 | $878.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $869.00K 10-Q · filed 2023-02-10 |
| 2022-09-30 | $757.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $510.00K 10-K · filed 2023-09-15 |
| 2022-03-31 | $506.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $501.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $499.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $500.00K 10-K · filed 2022-09-13 |
| 2021-03-31 | $495.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $493.00K 10-Q · filed 2021-02-12 |
| 2020-09-30 | $494.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $488.00K 10-K · filed 2021-09-02 |
| 2020-03-31 | $484.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $478.00K 10-Q · filed 2020-02-12 |
| 2019-09-30 | $474.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $470.00K 10-K · filed 2020-09-23 |